Healthcare -
Biotechnology - NASDAQ - US
$ 2.89
-1.03 %
$ 1.75 B
Market Cap
-9.03
P/E
GERN - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss GERN - Geron Corporation
185 K
LAST VALUE
75.20%
2 YEAR CAGR
24.66%
5 YEAR CAGR
31.29%
10 YEAR CAGR